Clinical Trials Directory

Trials / Unknown

UnknownNCT05040334

Role of Prophylactic Antibiotics in Preventing Pelvic Infection After Surgical Evacuation

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
138 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

To determine the role of antibiotic prophylaxis in the surgical management of miscarriage.

Detailed description

Patients will be randomized to receive either prophylactic antibiotic \[a single dose of oral doxycycline (200 mg) and metronidazole (500 mg)\] or placebo using identical sealed envelopes.Included cases are those with early miscarriage (within the first trimester 12 6/7 weeks of gestation) , missed or incomplete miscarriage, undergoing surgical management will be included in the study. Technique: The investigators will prepare 138 identical envelops, half of them filled with a label group(1) who are the group to receive the antibiotic prophylaxis with all instruction details, while the other half filled with a label identifying ( group 2) who are the placebo group. All envelops will be prepared by the investigator and sealed before starting enrollment. After enrollment, each participant will be allowed to choose one envelop to determine to which group the patient will be assigned to.

Conditions

Interventions

TypeNameDescription
DRUGGroup 1: Antibiotic receiving groupGroup 1; receiving antibiotic prophylaxis; single dose of oral doxycycline (200 mg) tablet and metronidazole (500 mg) tablet 2 hours before the surgical evacuation Group B ;receiving placebo 2 hours before the surgical evacuation

Timeline

Start date
2021-01-01
Primary completion
2022-04-01
Completion
2022-05-01
First posted
2021-09-10
Last updated
2022-03-28

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05040334. Inclusion in this directory is not an endorsement.